Julita Kulbacka

Prof. Julita Kulbacka

Department of Molecular and Cellular Biology, Wroclaw Medical University, Wroclaw, Poland
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
SKStanisław Kwiatkowski
Stanisław Kwiatkowski
BKBartosz Knap
Bartosz Knap
DPDawid Przystupski
Dawid Przystupski
JSJolanta Saczko
Jolanta Saczko
EKEwa Kędzierska
Ewa Kędzierska
Julita KulbackaJulita Kulbacka
Julita Kulbacka

26 July 2020 in Journal of Bioenergetics and Biomembranes
Verified
Journal Article
Open access
PDF file
WSWojciech Kacper Szlasa
Wojciech Kacper Szlasa
IZIga Zendran
Iga Zendran
AZAleksandra Zalesińska
Aleksandra Zalesińska
MTMounir Tarek
Mounir Tarek
Julita KulbackaJulita Kulbacka
Julita Kulbacka
Cancer cell possesses numerous adaptations to resist the immune system response and chemotherapy. One of the most significant properties of the neoplastic cells is the altered lipid metabolism, and consequently, the abnormal cell membrane composition. Like in the case of phosphatidylcholine, these changes result in the modulation of certain enzymes and accumulation of energetic material, which could be used for a higher proliferation rate. The changes are so prominent, that some lipids, such as phosphatidylserines, could even be considered as the cancer biomarkers. Additionally, some changes of biophysical properties of cell membranes lead to the higher resistance to chemotherapy, and finally to the disturbances in signalling pathways. Namely, the increased levels of certain lipids, like for instance phosphatidylserine, lead to the attenuation of the immune system response. Also, changes in lipid saturation prevent the cells from demanding conditions of the microenvironment. Particularly interesting is the significance of cell membrane cholesterol content in the modulation of metastasis. This review paper discusses the roles of each lipid type in cancer physiology. The review combined theoretical data with clinical studies to show novel therapeutic options concerning the modulation of cell membranes in oncology.

4 April 2019 in Current Microbiology
Verified
Journal Article
Open access
PDF file
AGAgata Górska
Agata Górska
DPDawid Przystupski
Dawid Przystupski
MNMagdalena J. Niemczura
Magdalena J. Niemczura
Julita KulbackaJulita Kulbacka
Julita Kulbacka
Gut microbiota is widely considered to be one of the most important components to maintain balanced homeostasis. Looking forward, probiotic bacteria have been shown to play a significant role in immunomodulation and display antitumour properties. Bacterial strains could be responsible for detection and degradation of potential carcinogens and production of short-chain fatty acids, which affect cell death and proliferation and are known as signaling molecules in the immune system. Lactic acid bacteria present in the gut has been shown to have a role in regression of carcinogenesis due to their influence on immunomodulation, which can stand as a proof of interaction between bacterial metabolites and immune and epithelial cells. Probiotic bacteria have the ability to both increase and decrease the production of anti-inflammatory cytokines which play an important role in prevention of carcinogenesis. They are also capable of activating phagocytes in order to eliminate early-stage cancer cells. Application of heat-killed probiotic bacteria coupled with radiation had a positive influence on enhancing immunological recognition of cancer cells. In the absence of active microbiota, murine immunity to carcinogens has been decreased. There are numerous cohort studies showing the correlation between ingestion of dairy products and the risk of colon and colorectal cancer. An idea of using probiotic bacteria as vectors to administer drugs has emerged lately as several papers presenting successful results have been revealed. Within the next few years, probiotic bacteria as well as gut microbiota are likely to become an important component in cancer prevention and treatment.

10 February 2021 in Materials
Verified
Journal Article
Open access
PDF file
Magdalena ŁabowskaMagdalena Łabowska
Magdalena Łabowska
KCKarolina Cierluk
Karolina Cierluk
Agnieszka JankowskaAgnieszka Jankowska
Agnieszka Jankowska
Julita KulbackaJulita Kulbacka
Julita Kulbacka
Jerzy DetynaJerzy Detyna
Jerzy Detyna
Izabela MichalakIzabela Michalak
Izabela Michalak
Sustaining the vital functions of cells outside the organism requires strictly defined parameters. In order to ensure their optimal growth and development, it is necessary to provide a range of nutrients and regulators. Hydrogels are excellent materials for 3D in vitro cell cultures. Their ability to retain large amounts of liquid, as well as their biocompatibility, soft structures, and mechanical properties similar to these of living tissues, provide appropriate microenvironments that mimic extracellular matrix functions. The wide range of natural and synthetic polymeric materials, as well as the simplicity of their physico-chemical modification, allow the mechanical properties to be adjusted for different requirements. Sodium alginate-based hydrogel is a frequently used material for cell culture. The lack of cell-interactive properties makes this polysaccharide the most often applied in combination with other materials, including gelatin. The combination of both materials increases their biological activity and improves their material properties, making this combination a frequently used material in 3D printing technology. The use of hydrogels as inks in 3D printing allows the accurate manufacturing of scaffolds with complex shapes and geometries. The aim of this paper is to provide an overview of the materials used for 3D cell cultures, which are mainly alginate–gelatin hydrogels, including their properties and potential applications.

11 August 2023 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Open access
PDF file
NSNatalia Sauer
Natalia Sauer
NJNatalia Janicka
Natalia Janicka
WSWojciech Szlasa
Wojciech Szlasa
BSBartłomiej Skinderowicz
Bartłomiej Skinderowicz
KKKatarzyna Kołodzińska
Katarzyna Kołodzińska
KKKatarzyna Karłowicz-Bodalska
Katarzyna Karłowicz-Bodalska
T-cell immunoglobulin and mucin domain-containing protein 3 (TIM-3) expression has been a trending topic in recent years due to its differential expression in a wide range of neoplasms. TIM-3 is one of the key immune checkpoint receptors that interact with GAL-9, PtdSer, HMGB1 and CEACAM1. Initially identified on the surface of T helper 1 (Th1) lymphocytes and later on cytotoxic lymphocytes (CTLs), monocytes, macrophages, natural killer cells (NKs), and dendritic cells (DCs), TIM-3 plays a key role in immunoregulation. Recently, a growing body of evidence has shown that its differential expression in various tumor types indicates a specific prognosis for cancer patients. Here, we discuss which types of cancer TIM-3 can serve as a prognostic factor and the influence of coexpressed immune checkpoint inhibitors, such as LAG-3, PD-1, and CTLA-4 on patients' outcomes. Currently, experimental medicine involving TIM-3 has significantly enhanced the anti-tumor effect and improved patient survival. In this work, we summarized clinical trials incorporating TIM-3 targeting monoclonal and bispecific antibodies in monotherapy and combination therapy and highlighted the emerging role of cell-based therapies.

1 November 2013 in Food Chemistry
Verified
Journal Article
Closed access
IBIzabela Berdowska
Izabela Berdowska
BZBogdan Zieliński
Bogdan Zieliński
IFIzabela Fecka
Izabela Fecka
Julita KulbackaJulita Kulbacka
Julita Kulbacka
JSJolanta Saczko
Jolanta Saczko
AGAndrzej Gamian
Andrzej Gamian